These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19146640)

  • 1. Parkinson's disease and nursing home placement: the economic impact of the need for care.
    Vossius C; Nilsen OB; Larsen JP
    Eur J Neurol; 2009 Feb; 16(2):194-200. PubMed ID: 19146640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience of care home residents with Parkinson's disease: Reason for admission and service use.
    Walker RW; Palmer J; Stancliffe J; Wood BH; Hand A; Gray WK
    Geriatr Gerontol Int; 2014 Oct; 14(4):947-53. PubMed ID: 24320887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of illness and its predictors for Parkinson's disease in Germany.
    Spottke AE; Reuter M; Machat O; Bornschein B; von Campenhausen S; Berger K; Koehne-Volland R; Rieke J; Simonow A; Brandstaedter D; Siebert U; Oertel WH; Ulm G; Dodel R
    Pharmacoeconomics; 2005; 23(8):817-36. PubMed ID: 16097843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease.
    Kaltenboeck A; Johnson SJ; Davis MR; Birnbaum HG; Carroll CA; Tarrants ML; Siderowf AD
    Parkinsonism Relat Disord; 2012 May; 18(4):321-6. PubMed ID: 22177623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
    Cubo E; Martínez Martin P; González M; Frades B;
    Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK.
    Weir S; Samnaliev M; Kuo TC; Tierney TS; Walleser Autiero S; Taylor RS; Schrag A
    Mov Disord; 2018 Jul; 33(6):974-981. PubMed ID: 29603405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
    Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
    J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease and hospital admissions: frequencies, diagnoses and costs.
    Vossius C; Nilsen OB; Larsen JP
    Acta Neurol Scand; 2010 Jan; 121(1):38-43. PubMed ID: 19744137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of nursing home patients on general practitioners' workload.
    Groom L; Avery AJ; Boot D; O'Neill C; Thornhill K; Brown K; Jones R
    Br J Gen Pract; 2000 Jun; 50(455):473-6. PubMed ID: 10962786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease.
    Fernandez HH; Lapane KL
    Med Sci Monit; 2002 Apr; 8(4):CR241-6. PubMed ID: 11951064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs of dementia from the societal perspective: is care provided in the community really cheaper than nursing home care?
    König HH; Leicht H; Brettschneider C; Bachmann C; Bickel H; Fuchs A; Jessen F; Köhler M; Luppa M; Mösch E; Pentzek M; Werle J; Weyerer S; Wiese B; Scherer M; Maier W; Riedel-Heller SG;
    J Am Med Dir Assoc; 2014 Feb; 15(2):117-26. PubMed ID: 24321877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current and projected economic burden of Parkinson's disease in the United States.
    Kowal SL; Dall TM; Chakrabarti R; Storm MV; Jain A
    Mov Disord; 2013 Mar; 28(3):311-8. PubMed ID: 23436720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the costs associated with malnutrition in Dutch nursing homes.
    Meijers JM; Halfens RJ; Wilson L; Schols JM
    Clin Nutr; 2012 Feb; 31(1):65-8. PubMed ID: 21880401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
    Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.
    Goetz CG; Stebbins GT
    Neurology; 1995 Apr; 45(4):669-71. PubMed ID: 7723953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
    Hagell P; Nordling S; Reimer J; Grabowski M; Persson U
    Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact analysis of an end-of-life programme for nursing home residents.
    Teo WS; Raj AG; Tan WS; Ng CW; Heng BH; Leong IY
    Palliat Med; 2014 May; 28(5):430-7. PubMed ID: 24651709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ownership and ownership change on nursing home industry costs.
    Holmes JS
    Health Serv Res; 1996 Aug; 31(3):327-46. PubMed ID: 8698588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the burden and mortality of hospitalisation in Parkinson's disease: A cross-sectional analysis of the English Hospital Episodes Statistics database 2009-2013.
    Low V; Ben-Shlomo Y; Coward E; Fletcher S; Walker R; Clarke CE
    Parkinsonism Relat Disord; 2015 May; 21(5):449-54. PubMed ID: 25737205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.